Successful conversion from thiazide to tolvaptan in a patient with stage D heart failure and chronic kidney disease before heart transplantation

Teruhiko Imamura, Koichiro Kinugawa*, Naoko Kato, Shun Minatsuki, Hironori Muraoka, Toshiro Inaba, Hisataka Maki, Taro Shiga, Masaru Hatano, Atsushi Yao, Shunei Kyo, Minoru Ono, Issei Komuro

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Chronic kidney disease (CKD) is often complicated with advanced heart failure because of not only renal congestion and decreased renal perfusion but also prolonged use of diuretics at higher doses, which sometimes results in hyponatremia. Preoperative CKD is known to be associated with poor prognosis after heart transplantation (HTx). We experienced a stage D heart failure patient with CKD and hyponatremia who was switched from trichlormethiazide to tolvaptan. His hyponatremia was normalized, and his renal function was improved after conversion to tolvaptan. In patients with stage D heart failure, it may be useful to administer tolvaptan with a concomitant reduction in the dose of diuretics in order to preserve renal function and avoid hyponatremia before HTx.

Original languageEnglish
Pages (from-to)48-50
Number of pages3
JournalInternational Heart Journal
Volume54
Issue number1
DOIs
StatePublished - 2013/02

Keywords

  • Diuretics
  • Hyponatremia
  • Renal dysfunction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Successful conversion from thiazide to tolvaptan in a patient with stage D heart failure and chronic kidney disease before heart transplantation'. Together they form a unique fingerprint.

Cite this